$UnitedHealth(UNH)$ UnitedHealth Group (NYSE: UNH), the largest U.S. health insurer and one of Warren Buffett’s enduring portfolio holdings, is set to report its latest quarterly earnings on Tuesday. As investors brace for the results, all eyes are on whether the company can reaffirm its reputation as a defensive giant in a volatile healthcare landscape. With shares rebounding more than 40% from August lows, confidence is returning — but the question remains: is UnitedHealth still undervalued, and can it continue to deliver the kind of long-term stability that made it a Berkshire Hathaway favorite? A Comeback Story: From August Lows to Renewed Strength UnitedHealth’s stock performance over the past few months has been a story of sharp recovery. Aft
UNH Lifts 2025 Outlook! Earnings Got Healthier, Still Have Chance?
UnitedHealth raised its full-year 2025 earnings guidance, now expecting adjusted EPS of at least $16.25, up from the previous forecast of at least $16.00. The stock jumped in pre-market trading, reaching over $380. Have you hopped on UNH yet? After a 40% rebound this year, does UNH still have more upside ahead? Is UNH a solid stock for steady growth?
+ Follow
+5